Cancer Biopsy Market Size, Share, Trends, Growth Outlook

Cancer Biopsy Market is estimated to increase at a growth rate of 11.5% CAGR over the forecast period from 2024 to 2030.

 

The Cancer Biopsy Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Instruments, Kits and Consumables, Services), By Type (Tissue Biopsies, Liquid Biopsies, Others), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Liver Cancers, Pancreatic Cancers, Ovarian Cancers, Others).

 

An Introduction to Cancer Biopsy Market in 2024

The cancer biopsy market in 2024 addresses the demand for diagnostic procedures used to obtain tissue samples from suspicious lesions or tumors for pathological analysis and molecular testing. Biopsy techniques include fine-needle aspiration, core needle biopsy, excisional biopsy, and endoscopic biopsy, allowing clinicians to establish a definitive diagnosis, determine tumor histology and grade, and guide treatment decisions. Market growth is driven by factors such as the increasing incidence of cancer, the importance of accurate diagnosis for personalized treatment approaches, and technological advancements enhancing biopsy precision and sample yield. Collaboration between medical device manufacturers, pathologists, and oncologists drives innovation in biopsy instruments and techniques, supporting early detection and improved management of cancer for better patient outcomes.

 

Cancer Biopsy Market Trend: Shift Towards Minimally Invasive Biopsy Procedures

A significant trend in the Cancer Biopsy market is the increasing adoption of minimally invasive biopsy procedures. As technology advances and healthcare preferences evolve, there is a notable shift towards less invasive methods for diagnosing cancer, such as liquid biopsies and image-guided needle biopsies. These techniques offer advantages such as reduced patient discomfort, shorter recovery times, and the ability to obtain samples from inaccessible or difficult-to-reach areas, driving the demand for minimally invasive biopsy solutions.

Cancer Biopsy Market Driver: Growing Incidence of Cancer Worldwide

A key driver for the Cancer Biopsy market is the growing incidence of cancer globally. With cancer rates continuing to rise due to factors such as aging populations, lifestyle changes, and environmental factors, there is an increasing need for accurate and timely cancer diagnosis. Biopsy procedures play a crucial role in the diagnosis and staging of cancer, enabling healthcare providers to determine the presence, type, and extent of cancerous lesions, thus driving the demand for biopsy devices and services.

Cancer Biopsy Market Opportunity: Development of Next-Generation Biomarkers

One potential opportunity in the Cancer Biopsy market lies in the development of next-generation biomarkers for improved cancer detection and characterization. Advances in molecular biology and genomics have led to the identification of novel biomarkers that can provide valuable insights into cancer biology, prognosis, and treatment response. By investing in research and development efforts to identify and validate new biomarkers, companies in the Cancer Biopsy market can enhance the accuracy and specificity of cancer diagnostics, paving the way for personalized treatment approaches and better patient outcomes.

 

Cancer Biopsy Market Segmentation

 

By Product

Instruments

Kits and Consumables

Services

By Type

Tissue Biopsies

-Needle Biopsies

-Fine Needle Aspiration (FNA)

-Core Needle Biopsy (CNB)

-Surgical Biopsies

Liquid Biopsies

Others

By Application

Breast Cancer

Colorectal Cancer

Cervical Cancers

Lung Cancers

Prostate Cancers

Skin Cancers

Blood Cancers

Kidney Cancers

Liver Cancers

Pancreatic Cancers

Ovarian Cancers

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

 

Cancer Biopsy Market Companies

ANGLE Plc

Becton, Dickinson and Company

Biocept Inc

Biodesix (Integrated Diagnostics)

Chronix Biomedical Inc

Danaher

Epigenomics AG

Exact Sciences Corp

F. Hoffmann-La Roche Ltd

Freenome Holdings Inc

Genesystems Inc (Genesys Biolabs)

GRAIL Inc

Guardant Health

HelioHealth (Laboratory for Advanced Medicine)

Hologic Inc

Illumina Inc

Lucence Diagnostics Pte. Ltd

Myriad Genetics

Natera Inc

Oncimmune

Personal Genome Diagnostics Inc

Personalis Inc

Qiagen N.V.

Thermo Fisher Scientific Inc

 

Reasons to Buy the Cancer Biopsy Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Cancer Biopsy Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Cancer Biopsy Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

 

1 Introduction to 2024 Cancer Biopsy Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Cancer Biopsy Market Size Outlook, $ Million, 2021 to 2030

3.2 Cancer Biopsy Market Outlook By Type, $ Million, 2021 to 2030

3.3 Cancer Biopsy Market Outlook By Product, $ Million, 2021 to 2030

3.4 Cancer Biopsy Market Outlook By Application, $ Million, 2021 to 2030

3.5 Cancer Biopsy Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Cancer Biopsy Market Industry

4.2 Key Market Trends in Cancer Biopsy Market Industry

4.3 Potential Opportunities in Cancer Biopsy Market Industry

4.4 Key Challenges in Cancer Biopsy Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Cancer Biopsy Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Cancer Biopsy Market Outlook By Segments

7.1 Cancer Biopsy Market Outlook by Segments

By Product

Instruments

Kits and Consumables

Services

By Type

Tissue Biopsies

-Needle Biopsies

-Fine Needle Aspiration (FNA)

-Core Needle Biopsy (CNB)

-Surgical Biopsies

Liquid Biopsies

Others

By Application

Breast Cancer

Colorectal Cancer

Cervical Cancers

Lung Cancers

Prostate Cancers

Skin Cancers

Blood Cancers

Kidney Cancers

Liver Cancers

Pancreatic Cancers

Ovarian Cancers

Others

 

8 North America Cancer Biopsy Market Analysis And Outlook To 2030

8.1 Introduction to North America Cancer Biopsy Markets in 2024

8.2 North America Cancer Biopsy Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Cancer Biopsy Market size Outlook by Segments, 2021-2030

By Product

Instruments

Kits and Consumables

Services

By Type

Tissue Biopsies

-Needle Biopsies

-Fine Needle Aspiration (FNA)

-Core Needle Biopsy (CNB)

-Surgical Biopsies

Liquid Biopsies

Others

By Application

Breast Cancer

Colorectal Cancer

Cervical Cancers

Lung Cancers

Prostate Cancers

Skin Cancers

Blood Cancers

Kidney Cancers

Liver Cancers

Pancreatic Cancers

Ovarian Cancers

Others

 

9 Europe Cancer Biopsy Market Analysis And Outlook To 2030

9.1 Introduction to Europe Cancer Biopsy Markets in 2024

9.2 Europe Cancer Biopsy Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Cancer Biopsy Market Size Outlook By Segments, 2021-2030

By Product

Instruments

Kits and Consumables

Services

By Type

Tissue Biopsies

-Needle Biopsies

-Fine Needle Aspiration (FNA)

-Core Needle Biopsy (CNB)

-Surgical Biopsies

Liquid Biopsies

Others

By Application

Breast Cancer

Colorectal Cancer

Cervical Cancers

Lung Cancers

Prostate Cancers

Skin Cancers

Blood Cancers

Kidney Cancers

Liver Cancers

Pancreatic Cancers

Ovarian Cancers

Others

 

10 Asia Pacific Cancer Biopsy Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Cancer Biopsy Markets in 2024

10.2 Asia Pacific Cancer Biopsy Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Cancer Biopsy Market size Outlook by Segments, 2021-2030

By Product

Instruments

Kits and Consumables

Services

By Type

Tissue Biopsies

-Needle Biopsies

-Fine Needle Aspiration (FNA)

-Core Needle Biopsy (CNB)

-Surgical Biopsies

Liquid Biopsies

Others

By Application

Breast Cancer

Colorectal Cancer

Cervical Cancers

Lung Cancers

Prostate Cancers

Skin Cancers

Blood Cancers

Kidney Cancers

Liver Cancers

Pancreatic Cancers

Ovarian Cancers

Others

 

11 South America Cancer Biopsy Market Analysis And Outlook To 2030

11.1 Introduction to South America Cancer Biopsy Markets in 2024

11.2 South America Cancer Biopsy Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Cancer Biopsy Market size Outlook by Segments, 2021-2030

By Product

Instruments

Kits and Consumables

Services

By Type

Tissue Biopsies

-Needle Biopsies

-Fine Needle Aspiration (FNA)

-Core Needle Biopsy (CNB)

-Surgical Biopsies

Liquid Biopsies

Others

By Application

Breast Cancer

Colorectal Cancer

Cervical Cancers

Lung Cancers

Prostate Cancers

Skin Cancers

Blood Cancers

Kidney Cancers

Liver Cancers

Pancreatic Cancers

Ovarian Cancers

Others

 

12 Middle East And Africa Cancer Biopsy Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Cancer Biopsy Markets in 2024

12.2 Middle East and Africa Cancer Biopsy Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Cancer Biopsy Market size Outlook by Segments, 2021-2030

By Product

Instruments

Kits and Consumables

Services

By Type

Tissue Biopsies

-Needle Biopsies

-Fine Needle Aspiration (FNA)

-Core Needle Biopsy (CNB)

-Surgical Biopsies

Liquid Biopsies

Others

By Application

Breast Cancer

Colorectal Cancer

Cervical Cancers

Lung Cancers

Prostate Cancers

Skin Cancers

Blood Cancers

Kidney Cancers

Liver Cancers

Pancreatic Cancers

Ovarian Cancers

Others

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

ANGLE Plc

Becton, Dickinson and Company

Biocept Inc

Biodesix (Integrated Diagnostics)

Chronix Biomedical Inc

Danaher

Epigenomics AG

Exact Sciences Corp

F. Hoffmann-La Roche Ltd

Freenome Holdings Inc

Genesystems Inc (Genesys Biolabs)

GRAIL Inc

Guardant Health

HelioHealth (Laboratory for Advanced Medicine)

Hologic Inc

Illumina Inc

Lucence Diagnostics Pte. Ltd

Myriad Genetics

Natera Inc

Oncimmune

Personal Genome Diagnostics Inc

Personalis Inc

Qiagen N.V.

Thermo Fisher Scientific Inc

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Cancer Biopsy Market Segmentation

 

By Product

Instruments

Kits and Consumables

Services

By Type

Tissue Biopsies

-Needle Biopsies

-Fine Needle Aspiration (FNA)

-Core Needle Biopsy (CNB)

-Surgical Biopsies

Liquid Biopsies

Others

By Application

Breast Cancer

Colorectal Cancer

Cervical Cancers

Lung Cancers

Prostate Cancers

Skin Cancers

Blood Cancers

Kidney Cancers

Liver Cancers

Pancreatic Cancers

Ovarian Cancers

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)